Kospi plunges 13% as South Korea vows new measures to curb ETF speculation

source:

[1] South Korea: Will take more measures to stabilize the stock market, considering raising transaction costs to curb ETF speculation (https://wallstreetcn.com/articles/3778238 ...)[2] Korean stocks plunge as much as 13% in burst of retail selling (https://businessmirror.com.ph/2026/07/29/kore ...)[3] Top South Korean policy makers apologise for single-stock leveraged ETFs (https://www.reuters.com/world/top-south-korea ...)[4] Analysts react to rout in South Korea stocks (https://www.msn.com/en-us/money/markets/analy ...)[5] Minister apologizes as Korean leveraged ETF investors nurse heavy losses amid chip stock rout (https://www.msn.com/en-us/money/markets/minis ...)

Related News

Jul 29 2026, 13:32

Google DeepMind disbands Nobel-winning AlphaFold team in 2026 pivot

**Google DeepMind has dismantled the team behind its Nobel Prize-winning AlphaFold system, reassigning researchers to Gemini-focused projects.** Google DeepMind has disbanded the research group that produced AlphaFold, the AI system that solved biology's 50-year-old protein folding problem and earned the lab its 2024 Nobel Prize in Chemistry, according to a Financial Times report Wednesday. The move reassigns most of the team's key members to projects centered on the Gemini large language model, while roughly a quarter of the group has left the company entirely. "Google has reassigned most of the team's key members and the original authors of its papers, while a few others have already left the company," the Financial Times reported, citing people familiar with the restructuring. The shakeup reflects a broader strategic shift at DeepMind away from dedicated scientific research teams toward building general-purpose AI systems that can assist across multiple scientific domains. The AlphaFold team's dissolution comes with notable departures. John Jumper, who shared the 2024 Nobel Prize in Chemistry with DeepMind CEO Demis Hassabis for his work leading AlphaFold, left the company in June for Anthropic after nearly nine years. Two other AlphaFold authors — Jonas Adler and Alexander Pritzel, both of whom also contributed to Gemini — followed Jumper to Anthropic, Bloomberg reported. Other former staff members were reassigned to Isomorphic Labs, Alphabet's drug-discovery spin-off that builds on AlphaFold's technology. **The Gemini-first strategy** The restructuring represents Google's decision to concentrate resources on Gemini, its flagship AI model competing with OpenAI's GPT and Anthropic's Claude. Pushmeet Kohli, vice president of research at Google DeepMind, told the Financial Times that the lab's strategy has evolved from focusing on individual grand challenges toward broader AI capabilities. "Our strategy over the last nine years has been to focus on grand challenges... a concrete goal every project is focused on," Kohli said. "The strategy has evolved." The shift carries risks. AlphaFold was DeepMind's most tangible scientific achievement — a system that predicted over 200 million protein structures and attracted more than 3 million users across 190 countries. The Nobel committee credited AlphaFold2 with helping researchers understand antibiotic resistance and create enzymes capable of decomposing plastic. Disbanding the team that delivered that credibility in the same period that key talent migrates to Anthropic raises questions about Google's ability to retain top AI researchers. **What it means for investors** For Alphabet investors, the restructuring signals a bet that general-purpose AI models will ultimately generate more value than specialized scientific tools. DeepMind's new direction envisions Gemini-powered systems that can assist scientists across biology, chemistry and physics — potentially automating parts of research that currently require dedicated teams. But the near-term cost is visible: the loss of Jumper, Adler and Pritzel to Anthropic, and the departure of Noam Shazeer — a Gemini co-lead and co-author of the foundational 2017 Transformer paper — to OpenAI, contributed to a roughly 5% decline in Alphabet shares in late June, according to Bloomberg. Anthropic now holds three AlphaFold veterans with direct experience building AI systems that millions of researchers trust. If Anthropic applies that expertise to scientific applications within Claude, it could narrow Google's lead in AI-driven drug discovery and materials science — areas where DeepMind had established a clear advantage. Alphabet shares, trading at roughly 22 times forward earnings, face the added challenge of proving that breaking up its most celebrated science team was a strategic necessity rather than a misstep. This article is for informational purposes only and does not constitute investment advice.

Jul 29 2026, 13:30

Warren, Schiff press SEC to probe Trump Media's $100,000 data feed

**Democratic senators are pressing the SEC to investigate whether Trump Media's plan to sell early access to President Donald Trump's social media posts violates securities laws.** Democratic Senators Elizabeth Warren and Adam Schiff asked the U.S. Securities and Exchange Commission on Tuesday to probe whether Truth Social parent Trump Media's plan to sell early access to President Donald Trump's social media posts for as much as $100,000 a month violates securities laws. "This appears to be an outrageous abuse of the President's office for his personal benefit that undermines everyday investors and the integrity of our markets, while enriching Wall Street and other wealthy insiders," Warren and Schiff said in a July 28 letter to SEC Chairman Paul Atkins, a copy of which was reviewed by Reuters. Trump Media, which owns Truth Social, plans to launch the Truth API product Aug. 1, offering trading firms the fastest access to posts from the platform's 10 most influential accounts, including Trump's. The company has discussed charging as much as $100,000 a month for the feed and said it has already signed up customers, though it did not identify them. Trump, who owns about 41% of Trump Media through a trust his children oversee, stands to profit directly from the arrangement. The product raises novel legal questions about whether a sitting president's social media posts constitute government information that must be disseminated to the public free of charge, and whether monetizing early access to them violates insider trading laws. Trump has previously used Truth Social to endorse specific stocks including Citigroup, Intel and Palantir, which the senators said heightens the risk of market manipulation and undermines confidence that the market operates on a level playing field. While technology platforms are generally permitted to offer clients early data access, even if it disadvantages some market participants, ethics experts have argued the Truth API product is different because Trump's posts carry unique market-moving power and he has an obligation to disseminate government information publicly. Trump's social media posts have in the past moved markets, and the profits of many top trading firms, hedge funds and financial services firms depend heavily on the speed at which they can trade off such news. The SEC, led by Atkins — a free-market Republican appointed by Trump who has generally taken a softer stance on enforcement — confirmed receiving the letter but declined to comment further. Trump Media and the White House did not respond to requests for comment. The product is scheduled to launch Aug. 1, and an SEC probe could complicate Trump Media's efforts to monetize the president's social media presence, a key revenue driver for the company. The letter is the latest example of Democratic lawmakers scrutinizing Trump's mixing of personal business with presidential affairs. Trump reported last month that he received more than $1.4 billion last year from his family's crypto projects, adding to concerns about conflicts of interest. This article is for informational purposes only and does not constitute investment advice.

Jul 29 2026, 13:26

Lemonade revenue jumps 79% as path to profitability narrows

Lemonade reported Q2 revenue of $294 million, up 79% year over year, as in-force premium reached $1.43 billion. "We remain on track to deliver our first positive adjusted EBITDA quarter in Q4 of this year, followed by a positive adjusted EBITDA full year 2027," Chief Executive Officer and Co-founder Daniel Schreiber said. The company's gross profit climbed 76% to a record $113 million. Net loss narrowed to $43 million, or 56 cents a share, from $44 million, or 60 cents, a year earlier. Adjusted EBITDA loss shrank to $19 million from $41 million, while adjusted free cash flow turned positive for the fifth consecutive quarter at $19 million. The results extend Lemonade's streak of accelerating in-force premium growth to 11 consecutive quarters. The company raised its full-year revenue guidance to approximately 65% growth and reiterated its expectation for positive adjusted EBITDA in the fourth quarter. In-force premium rose 32.5% year over year to $1.43 billion, matching the company's 33% growth guidance for the third quarter and full year. Customer count grew 23% to roughly 166,000 new customers added during the quarter, while premium per customer increased 8%. Annual dollar retention held steady at 85%. Lemonade's car insurance business expanded 60% year over year, with cross-sales representing 40% to 50% of new car policies. The company launched 14 new state-product combinations in the past 100 days, including its autonomous-car product in Colorado and Indiana. The gross loss ratio came in at 60%, including 7 percentage points of favorable prior-period development. Catastrophe impact was 3%. On the expense side, the claims-handling expense ratio fell to a record-low 5%, compared with an industry average of about 9%, President and Co-founder Shai Wininger said. Growth spending totaled $64 million in the quarter, up 30% from a year earlier, while the lifetime-value-to-customer-acquisition-cost ratio remained above 3 times. The company expects growth-spend growth to trail in-force premium growth beginning in 2027, supporting operating leverage. Lemonade secured $250 million in growth financing at an approximately 9.8% cost, which management said represents more than six percentage points of improvement in its cost of capital. The company ended the quarter with about $1.2 billion in cash and investments, including roughly $330 million required as regulatory surplus. Chief Financial Officer Tim Bixby will step down at year-end after more than nine years and join the board of directors. Senior Vice President of Finance Nick Stead will succeed him. Schreiber said the transition had been planned over several years. The guidance raise signals management expects accelerating demand to drive operating leverage. Investors will watch the Q3 earnings report for further progress on the path to positive adjusted EBITDA. This article is for informational purposes only and does not constitute investment advice.